Allan E. Rettie
Affiliations: | University of Washington, Seattle, Seattle, WA |
Area:
Pharmacology, BiochemistryWebsite:
https://sop.washington.edu/people/allan-rettie/Google:
"Allan Rettie"Bio:
https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.347325
DOI: 10.3109/00498258609043523
Mean distance: (not calculated yet)
Parents
Sign in to add mentorMichael David Rawlins | grad student | 1983 | Newcastle University | |
(Mixed-function oxidases in mammalian skin.) | ||||
Mont Rawlings Juchau | post-doc | 1987 | University of Washington | |
William F. Trager | post-doc | 1987 | University of Washington |
Children
Sign in to add traineeKirk R. Henne | grad student | 2001 | University of Washington |
Leslie J. Dickmann | grad student | 2003 | University of Washington |
Catherine K. Yeung | grad student | 2005 | University of Washington |
Guoying Tai | grad student | 2006 | University of Washington |
Carrie M. Mosher | grad student | 2008 | University of Washington |
Mariko Nakano | grad student | 2011 | University of Washington |
Clara K. Hsia | grad student | 2012 | University of Washington |
Oliver T. Parkinson | grad student | 2012 | University of Washington |
Nicholas T. Au | grad student | 2014 | University of Washington |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Röder A, Hüsken S, Hutter MC, et al. (2023) Spotlight on CYP4B1. International Journal of Molecular Sciences. 24 |
Kowalski JP, Pelletier RD, McDonald MG, et al. (2021) Pharmacokinetics, metabolism and off-target effects in the rat of 8-[(1H- benzotriazol-1-yl)amino]octanoic acid, a selective inhibitor of human cytochrome P450 4Z1: -oxidation as a potential augmenting pathway for inhibition. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 1-56 |
Henderson LM, Hopkins SE, Boyer BB, et al. (2021) Functional Effects of , a Novel and Common Variant in the Yup'ik Alaska Native Population. Drug Metabolism and Disposition: the Biological Fate of Chemicals |
Imaoka T, Yang J, Wang L, et al. (2020) Microphysiological System Modeling of Ochratoxin A-Associated Nephrotoxicity. Toxicology. 152582 |
Chiasson MA, Rollins NJ, Stephany JJ, et al. (2020) Multiplexed measurement of variant abundance and activity reveals VKOR topology, active site and human variant impact. Elife. 9 |
McDonald MG, Tian DD, Thummel KE, et al. (2020) Modulation of Major Human Liver Microsomal Cytochromes P450 by Component Alkaloids of Goldenseal: Time-Dependent Inhibition and Allosteric Effects. Drug Metabolism and Disposition: the Biological Fate of Chemicals |
McDonald MG, Henderson LM, Ray S, et al. (2020) Heterologous Expression and Functional Characterization of Novel CYP2C9 Variants Identified in the Alaska Native People. The Journal of Pharmacology and Experimental Therapeutics |
Kowalski JP, McDonald MG, Pelletier RD, et al. (2020) Design and Characterization of the First Selective and Potent Mechanism-Based Inhibitor of Cytochrome P450 4Z1. Journal of Medicinal Chemistry |
Fohner AE, Rettie AE, Thai KK, et al. (2020) Associations of CYP2C9 and CYP2C19 pharmacogenetic variation with phenytoin-induced cutaneous adverse drug reactions. Clinical and Translational Science |
Basit A, Prasad B, Estergreen JK, et al. (2020) A novel LC-MS/MS assay for quantification of des-carboxy prothrombin and characterization of warfarin induced changes. Clinical and Translational Science |